The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Dr. Olfson and Colleagues Reply

Published Online:

To the Editor: Our analysis of visits to office-based psychiatrists documented an overall decline in the duration of visits and an increase in the proportion of visits in which psychotropic medications are prescribed. Although we agree with Dr. Kahan that managed care offers a plausible explanation for much of the decrease in the duration of visits, we doubt that it fully explains the trend toward increasing prescriptions for psychotropic medications.

We have previously reported that a significant increase has occurred in the number of antidepressant prescriptions written for self-paying and privately insured patients (1). In our article, the decrease in the duration of visits disproportionately affected visits in which medications were not prescribed. For these reasons, we respectfully disagree with Dr. Kahan and continue to believe that new pharmacologic treatments and changing financial arrangements contributed to the reported changes in practice style.

References

1. Olfson M, Marcus SC, Pincus HA, Zito JM, Thompson JW, Zarin DA: Antidepressant prescribing practices of outpatient psychiatrists. Arch Gen Psychiatry 1998; 55:310–316Crossref, MedlineGoogle Scholar